BASL Annual Meeting delegates please remember that you can view all of the session recordings across BASL, BLTG and BLNA for at least 3 months post congress by logging back into the portal using your original log in link. 


21st - 24TH September 2021 - Registration closed

Thank you to everyone that contributed, supported, organised and attended the BASL Annual Meeting, the BLTG meeting and the BLNA nurse meeting that took place virtually from 21st - 24th September 2021 and for making the meetings a great success. We look forward to holding a face to face meeting next year and to announcing the dates and location for BASL2022.









The British Association for the Study of the Liver is a multi-disciplinary society with around 900 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions.

Read More

British Liver Nurses' Association is a professional nursing organisation aiming to develop knowledge and understanding of liver disease, in order to improve the quality of patient care.

Read More

The British Viral Hepatitis aims to improve the management and study of patients with chronic viral liver disease, bringing together UK hepatologists, gastroenterologists, infectious disease physicians, virologists and interested epidemiologists.

Read More

The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development. The BLTG will foster close relationships with BTS (British Transplant Society) and LICAGE (Liver Intensive Care Group of Europe) and will build on the role of the UK and Ireland Annual Meeting by delivering structure and authority to the group.

Read More

Is a professional pharmacy organisation aiming to develop knowledge and understanding of liver disorders including viral hepatitis, in order to improve the quality of patient care, through medicines optimisation, collaborative and multi-disciplinary working and promoting patient-focused research.

Read More

HCC UK is a multi-disciplinary organisation aiming to promote collaboration in research, education and clinical service development for primary liver cancer. We bring together leading oncologists, liver surgeons, hepatologists, basic scientists, radiologists, pathologists and specialist nurses to lead improvement in the quality of patient care.

Read More


Clinical Fellowship Hepatology - St James's University Hospital

News Type: BASL News

Job Title: Clinical Fellowship Hepatology
Specialty/Department: Department of Hepatology
Location: Leeds Liver Unit, St James’s University Hospital
Salary: Dependent on Experience
Job link: 

Applications are invited for a Clinical Fellowship available from September 2021 for 6 months renewable for a further 6 months in the Department of Hepatology at St James’s University Hospital in Leeds.

We are looking for an enthusiastic well-motivated trainee who wants the opportunity to gain experience in the management of liver disease.With a growing need for doctors to understand and be able to manage patients with liver disease, this is an exciting opportunity to train in one of the leading UK Hepatology centres and contribute to the Leeds Liver Unit’s international reputation for transplantation.

The successful candidate will gain experience in all aspects of Hepatology including the assessment of patients with acute and sub-acute liver failure, assessment of patients for treatments such as liver transplantation and TIPSS, patients with a wide variety of complex general Hepatological conditions and with viral hepatitis. This is a clinical post and the fellow will join the out of hours rota and have the opportunity to undertake audit and contribute to ongoing projects in the department.

The Department is affiliated to the University of Leeds with the MRC funded Centre for Bioinformatics, the Leeds Institute of Data Analysis and the NIHR funded Diagnostic Evaluation Co-operative.

Candidates should hold full licence to practise with the UK General Medical Council and have completed their Foundation Years training or equivalent.

Basic salary scale will depend upon experience. An out of hours banding supplement will also apply.

Interested applicants are welcome to contact Dr Mark Aldersley, Consultant Hepatologist and Lead Clinician by e-mail .

Closing date 27th September 2021.

Survey of HCC surveillance services in the UK 2021- an invitation to participate

News Type: BASL News

A survey of HCC surveillance in the UK was last conducted in 2014, which highlighted some weaknesses in service provision nationally. We are repeating the survey to see if things have changed, and extending the survey to include additional questions on surveillance imaging and secondary surveillance. We have worked with the HCC UK Committee in developing this survey, and the project is supported by BASL. We hope that this will generate a valuable contemporary overview of UK HCC surveillance service delivery, and stimulate discussion and innovation.

The link to the survey is found here > 

This time we are seeking service level responses (one response per organisation or service).We expect the survey will only take 10-15 minutes to complete, although some of the questions might require input from other clinical colleagues e.g. section 3 is about imaging and may require input from a radiologist. We will acknowledge the lead contributor from each organisation in a report of this survey.

Many thanks in advance for your time.

Dr Aloysious Aravinthan, Consultant Hepatologist, Nottingham University Hospitals NHS Trust
Dr James Franklin, Consultant Radiologist, University Hospitals Dorset NHS Foundation Trust
Dr Christopher Clarke, Consultant Radiologist, Nottingham University Hospitals NHS Trust
Professor Steve Ryder, Consultant Hepatologist, Nottingham University Hospitals NHS Trust
Professor Shahid Khan, Professor of Practice (Hepatology), Imperial College London


Gilead Sciences: UK & Ireland Viral Hepatitis Fellowship/Medical Grants Program

News Type: BASL News

In an effort to further address the unmet medical need in viral hepatitis, Gilead Sciences is launching a fellowship program.

The programme will support proposals that evaluate existing, or implement and evaluate new, innovative initiatives focussed on increasing appropriate Hepatitis Delta testing utilising electronic healthcare systems (e.g. automated reflex testing or pop-ups).

Applications will be accepted from 16th August and 15th October 2021.

For more information on Gilead Sciences Fellowship program and how to apply, please visit: .

IQILS Accreditation Programme Update

News Type: BASL News

The IQILS accreditation programme has grown significantly in the last 18 months. There has been a rapid increase in the level of engagement from services, committed to progressing with IQILS accreditation. The programme currently has 60 registered services, an increase of 8 services in 2021 alone. 11 services are currently signed off for the level 1 standards; A list of all these services can be found on the IQILS website. Three services will be undergoing a full accreditation assessment in the latter part of 2021.

The programme is also offering registered services, that are not an operational delivery hub for the Hepatitis C network, peer review support opportunities. The peer reviews are taking place remotely and will provide your service with an opportunity to receive feedback and guidance on how to progress with the accreditation standards.

In other news, Dragana Smith has recently been appointed as the new IQILS programme manager. Dragana previously worked as programme manager for the pulmonary rehabilitation accreditation programme, and prior to joining the Royal College of Physicians, worked in the fields of legal practice and medical education.

Registration to the programme is open to all liver services across the UK. If your service is interested in registering, please visit our website to sign up: 

Services registered to the programme receive access to the following benefits:
• The full accreditation standards
• Access to the IQILS website and self-assessment webtool
• Regular virtual training session on the accreditation process and standards
• Online repository of best practice templates and documents
• Regular newsletters on the programme with updates
• Support from the IQILS office team

Please contact the IQILS team at or 0203 3075 1508 if you would like to speak to the IQILS team about the programme.

IQILS Accreditation Programme - assessors needed

News Type: BASL News

The IQILS accreditation programme is seeking nurse and medical assessors to conduct accreditation assessments for the programme.

The IQILS programme was launched in 2017 and is designed to support liver services in the UK. Accreditation is a supportive process of evaluating the quality of clinical services against the programme’s established standards.

Successful applicants will undergo a detailed training programme that equips them with the necessary skills and knowledge required to undertake the role. You will be invited to remote training sessions, as well as observe an assessment and receive support from the office team.  If you are interested in becoming an assessor, please contact the IQILS team at to further discuss the role.



BASL Rare Disease SIG - Haemochromatosis sub-SIG meeting
News Type: BASL Events

Save the Date

The second meeting of the Haemochromatosis sub-SIG will take place on Thursday 28th October from 17:00 pm. 

Joining instructions will be sent to the Haemochromatosis sub-SIG members nearer the meeting date. 

If you are a BASL or BSG member and want to join this sub-SIG please contact 

29/10/21 - 30/10/21

Baveno VII – Consensus Workshop Personalized Care in Portal Hypertension
News Type: Other Events

Baveno VII is a sequel of the Baveno I-VI Workshops, which were held every 5 years from 1990 to 2015.

The workshop is being held virtually this year so very accessible to BASL members.

The aim of the Baveno VII Workshop is twofold: first, to review and put into perspective the changes in diagnostic and therapeutic strategies that have occurred in the past 5 years in the field of portal hypertension. Second, to continue the effort – which had begun in Baveno I thirty years ago – of producing updated definitions and guidelines aimed at improving the management of patients as well as the quality of our future studies.

The structure of the Workshop is similar to that of the previous ones – there will be 4 sessions: each divided into 2-3 parts.

The first session will concern the evaluation and risk stratification of patients with cirrhosis, focusing on the HVPG as a gold standard and on non-invasive surrogates for the diagnosis of compensated advanced chronic liver disease, clinically significant portal hypertension and varices.

The second session, dedicated to the new clinical scenarios will be divided into three parts. The first one will include four introductory lectures on progression and regression of cirrhosis; the second one will analyze the impact of etiological therapy for cirrhosis, and the third one will deal with the impact of non-etiological novel therapies in cirrhosis.

The third session will deal with the different clinical settings and will also be divided into three parts: the first one will be devoted to the prevention of (first) decompensation, the second one to acute variceal hemorrhage, and the third one to the prevention of further decompensation.

The fourth session will be devoted to vascular liver diseases in cirrhosis, and will consist of two parts: the first one on diagnosis and staging, and the second one to treatment. According to the Baveno tradition, at the end of each session, updated consensus statements on the topic of the session will be presented and discussed by the Panels and the Audience.

Visit the EASL website for more information on the programme and how to register; 


BASL Virtual School of Hepatology November 2021 - Session 11: HPB for Hepatologist
News Type: BASL Events

Registration now open

Are you a budding Hepatologist? Do you want to improve your Hepatology knowledge to help with core and higher Hepatology curriculum sign off? Have you got Hepatology questions but not had the opportunity to ask them?

If yes then please join us for the BASL Virtual School of Hepatology 2021. We are running a series of monthly webinars on a Wednesday evening.

Session 11: "HPB for Hepatologist "
Speaker: Dr Deepak Joshi, Kings College Hospital, London
Date: Wednesday 10th November
UK Time: 19:00 – 20:00

The BASL Virtual School of Hepatology Sessions offer an excellent platform for trainees interested in hepatology, with talks delivered by UK Hepatologists, followed by a Q&A session.

Preview the series programme  Download BASL Virtual School of Hepatology Series 2021_website7.pdf
NB: Subject to change

FREE to attend for BASL Members.

Not a member of BASL, then why not join by clicking > here.

REGISTER - through Zoom by clicking here . 

Remember to read the BASL Events Data Protection Disclaimer below before registering:

Download BASL Events Data Protection Disclaimer_2021.pdf

Please contact should you have any questions.

Thank you to our supporters:

     Platinum Sponsor:                                                     Gold Sponsor:                                 Bronze Sponsor:

'This webinar series is supported by Shionogi, Dr Falk Pharma UK and Intercept Pharma UK & Ireland. They have had no influence or input into the programme, agenda or content of the meeting’.


Introduction to IQILS Accreditation - virtual event
News Type: Other Events

Date: Tuesday 16 November 2021

Time: 09:30 – 10:30

The IQILS accreditation programme will be hosting a virtual event, for liver services in the UK to learn about the benefits of accreditation. Accreditation promotes quality improvement through highlighting areas of best practice and areas for change, encouraging the continued development of clinical services.

The programme was launched in July 2017, by the Royal College of Physicians' accreditation unit and currently has 60 services registered across the country.

During this session, delegates will learn about:
• What accreditation is and how it can add value to your service
• The process and logistics involved in accreditation
• The benefits of registering

The session will be led by Dr James Ferguson, IQILS clinical lead and Dr Andrew Yeoman, the QA lead of the IQILS programme.

The session will take place via Microsoft Office teams. Once you have registered, an invite will be sent to you with the dial in details.

Delegates can register here for the session.

If you have any questions about the session, please contact the IQILS team at .


BASL Portal Hypertension SIG Webinar - Updates on TIPSS for Ascites - Registration now open
News Type: BASL Events

BASL Portal Hypertension SIG Webinar - "Updates on TIPSS for Ascites"
Date: Wednesday 17th November 2021
Time: 18:00 - 19:00 GMT


Moderator: Prof Dhiraj Tripathi, University Hospitals Birmingham

• TIPSS for ascites: Optimal patient selection. Speaker: Prof Juan Carlos Garica-Pagan, Hospital Clinic, Barcelona
• Economic evaluation of TIPSS for ascites: Speaker: Prof Guru Aithal, Nottingham Digestive Diseases Centre, Nottingham
• Conclusion by moderator


Please read the BASL Events Data Protection Disclaimer below before registering:
Download BASL Events Data Protection Disclaimer_2021.pdf

You can register via the BASL website. The meeting is being held via Zoom.

BASL, BSG & SIG members welcome.

Not a BASL member, you can join by clicking HERE .

Please contact if you have any questions.

Thank you to our sponsor.

They have had no influence or input into the programme, agenda or content of the meeting.


Quick Links

Basl on Twitter